Contrast-enhanced ultrasonography (CEUS) immediately after percutaneous ablation of hepatocellular carcinoma

Gallotti, Anna; D’Onofrio, Mirko; Ruzzenente, Andrea; Martone, Enrico; Robertis, Riccardo De; Guglielmi, Alfredo; Mucelli, Roberto Pozzi

doi:10.1007/s11547-009-0436-0

Cited by 22 publications

(20 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, there is still controversy over the role of CEUS vs CECT in the treatment response evaluation of HCC after ablation, which is probably influenced by the individual opinion and familiarity with the techniques [16] . Frieser et al [56] has concluded that CEUS is equal to CECT in evaluating treatment response; Gallotti et al [57] found that CEUS was excellent in evaluating treatment response after RFA, whereas it was inadequate for evaluating treatment response after EA.…”

Section: Ceus-guided Percutaneous Biopsy and Therapymentioning

confidence: 99%

Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound

Zheng

Liu

2014

WJR

View full text Add to dashboard Cite

Hepatocellular carcinoma (HCC) is the sixth most common neoplasm and the third cause of cancer death worldwide. Contrast enhanced ultrasound (CEUS) has been applied for more than ten years and plays increasingly important roles in the management of HCC. On the basis of the Guideline and Good Clinical Practice Recommendations for CEUS in the liver-update 2012 and related literature about the management of HCC, we summarize the main roles and applications of CEUS in the management of HCC, including HCC surveillance, diagnosis, CEUS-guided treatment, treatment response evaluation and follow-up. The diagnostic algorithm for HCC is also suggested. Meanwhile, the comparisons between CEUS and contrast enhanced computed tomography/magnetic resonance imaging (CECT/CEMRI) in these areas are made. Although CEUS is subject to the same limitation as ordinary US and is inferior to CECT/CEMRI in some aspects, CEUS has proved to be of great value in the management of HCC with inherent advantages, such as sufficient high safety profile making it suitable for patients with renal failure or allergic to iodine, absence of radiation, easy reproducibility and high temporal resolution. The tremendous application of CEUS to the diagnosis and treatment of HCC provides more opportunities for patients with HCC diagnosed at different stages.

show abstract

Section: Ceus-guided Percutaneous Biopsy and Therapymentioning

confidence: 99%

Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound

Zheng

Liu

2014

WJR

View full text Add to dashboard Cite

show abstract

“…Since April 1998, 34 studies [35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69] that consider different CEUS techniques have been published. Of these, 23 were on harmonic gray-scale CEUS [48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70], 12 were on Doppler CEUS modalities [36,37,38,39,40,41,42,43,44,45,46,47,48], one study compared both approaches [48] and another reported on carbon dioxide CEUS [35] Two studies have been excluded from our discussion due to the unavailability of papers [71,72].…”

Section: Assessing Treatment Responsementioning

confidence: 99%

“…Of these, 23 were on harmonic gray-scale CEUS [48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70], 12 were on Doppler CEUS modalities [36,37,38,39,40,41,42,43,44,45,46,47,48], one study compared both approaches [48] and another reported on carbon dioxide CEUS [35] Two studies have been excluded from our discussion due to the unavailability of papers [71,72]. …”

Section: Assessing Treatment Responsementioning

confidence: 99%

“…Studies published on harmonic gray-scale CEUS for assessing the response to locoregional treatments encompass a total of 1,244 enrolled patients [42,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70]. Posttreatment assessment was made on 1,314 nodules in 16 studies following RFA [42,49,50,54,55,56,57,59,61,63,65,66,67,68,69,70], in 3 studies following PEI [57,59,67], and in 11 studies following TACE [49,50,51,52,53,57,60,62,64,66,69].…”

Section: Assessing Treatment Responsementioning

confidence: 99%

“…Posttreatment assessment was made on 1,314 nodules in 16 studies following RFA [42,49,50,54,55,56,57,59,61,63,65,66,67,68,69,70], in 3 studies following PEI [57,59,67], and in 11 studies following TACE [49,50,51,52,53,57,60,62,64,66,69]. Five of these studies also contemplated the use of combined treatments [49,50,57,67,69]. …”

Section: Assessing Treatment Responsementioning

confidence: 99%

See 2 more Smart Citations

Contrast-Enhanced Ultrasound Techniques for Guiding and Assessing Response to Locoregional Treatments for Hepatocellular Carcinoma

Andreana

Kudo²,

Hatanaka³

et al. 2010

Oncology

View full text Add to dashboard Cite

Most hepatocellular carcinomas (HCC) are diagnosed in patients with cirrhosis and/or when tumor burden is too advanced for surgical treatment. In many of these cases the only suitable therapy is locoregional, percutaneous and/or intraarterial treatment. Moreover, the best way to guide and assess response to locoregional HCC treatment are two issues under discussion today. First-generation and subsequent second-generation microbubble contrast agents, together with contrast-enhanced ultrasound (US) imaging, have expanded the role of US techniques in HCC treatments. In this review our purpose is to illustrate the advantages, limits and potential of contrast-enhanced US application for locoregional HCC treatment.

show abstract

Use of Ultrasound Contrast Agents in Relation to Percutaneous Interventional Procedures: A Systematic Review and Pictorial Essay

Nolsøe

Klubien

et al. 2017

J of Ultrasound Medicine

View full text Add to dashboard Cite

The aim of this article is to provide an inventory of the use of contrast-enhanced ultrasound (CEUS) in relation to percutaneous interventional procedures. The article is structured into a systematic literature review followed by a clinical part relating to percutaneous CEUS-guided procedures. A literature search identified 3109 records. After abstract screening, 55 articles were analyzed and supplemented with pictorial material to explain the techniques. In conclusion, the best-evidenced indications for CEUS-guided interventions are biopsy and ablation of inconspicuous or B-mode-invisible tumors, intraprocedural ablation control and follow-up, as well as percutaneous transhepatic cholangiography and drainage procedures.

show abstract

Contrast-enhanced ultrasonography (CEUS) immediately after percutaneous ablation of hepatocellular carcinoma

Abstract: CEUS performed immediately after percutaneous ablation of hepatocellular carcinoma to evaluate treatment efficacy is compulsory in the case of RFTA but not for PEI.

Cited by 22 publications

References 31 publications

Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound

Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound

Contrast-Enhanced Ultrasound Techniques for Guiding and Assessing Response to Locoregional Treatments for Hepatocellular Carcinoma

Use of Ultrasound Contrast Agents in Relation to Percutaneous Interventional Procedures: A Systematic Review and Pictorial Essay

Contact Info

Product

Resources

About